Barnes PM, Bloom B, Nahin R. CDC National Health Statistics Report #12. Complementary and alternative medicine use among adults and children: United States, 2007 2008 [cited 2019 April 20]. Available from: https://nccih.nih.gov/research/statistics/2007/camsurvey_fs1.htm. 20 April 2019
• Yoon SL, Grundmann O, Smith KF, Mason SR. Dietary supplement and complementary and alternative medicine use are highly prevalent in patients with gastrointestinal disorders: results from an online survey. J Diet Suppl. 2018;29:1–14. A recent internet-based survey revealed a high prevalence (84%) of use of dietary supplements and complementary and alternative medicine among respondents with a history of gastrointestinal symptoms.
Astin JA. Why patients use alternative medicine: results of a national study. Jama. 1998;279(19):1548–53.
Hung A, Kang N, Bollom A, Wolf JL, Lembo A. Complementary and alternative medicine use is prevalent among patients with gastrointestinal diseases. Dig Dis Sci. 2015;60(7):1883–8.
Vaezi MF, Yang YX, Howden CW. Complications of proton pump inhibitor therapy. Gastroenterology. 2017;153(1):35–48.
El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871–80.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308–28 quiz 29.
Ness-Jensen E, Hveem K, El-Serag H, Lagergren J. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological Association. 2016;14(2):175–82 e1–3.
Kaltenbach T, Crockett S, Gerson LB. Are lifestyle measures effective in patients with gastroesophageal reflux disease? An evidence-based approach. Arch Intern Med. 2006;166(9):965–71.
Nebel OT, Fornes MF, Castell DO. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976;21(11):953–6.
Feldman M, Barnett C. Relationships between the acidity and osmolality of popular beverages and reported postprandial heartburn. Gastroenterology. 1995;108(1):125–31.
Pointer SD, Rickstrew J, Slaughter JC, Vaezi MF, Silver HJ. Dietary carbohydrate intake, insulin resistance and gastro-oesophageal reflux disease: a pilot study in European- and African-American obese women. Aliment Pharmacol Ther. 2016;44(9):976–88.
Austin GL, Thiny MT, Westman EC, Yancy WS Jr, Shaheen NJ. A very low-carbohydrate diet improves gastroesophageal reflux and its symptoms. Dig Dis Sci. 2006;51(8):1307–12.
Morozov S, Isakov V, Konovalova M. Fiber-enriched diet helps to control symptoms and improves esophageal motility in patients with non-erosive gastroesophageal reflux disease. World J Gastroenterol. 2018;24(21):2291–9.
Gibson PR. History of the low FODMAP diet. J Gastroenterol Hepatol. 2017;32 Suppl 1:5–7.
Nam SY, Park BJ, Cho YA, Ryu KH, Choi IJ, Park S, et al. Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects. J Gastroenterol. 2017;52(7):818–29.
Mano F, Ikeda K, Sato T, Nakayama T, Tanaka D, Joo E, et al. Reduction in gastroesophageal reflux disease symptoms is associated with miso soup intake in a population-based cross-sectional study: the Nagahama study. J Nutr Sci Vitaminol. 2018;64(5):367–73.
Nam SY, Park BJ, Cho YA, Ryu KH. Gender-specific effect of micronutrient on non-erosive reflux disease and erosive esophagitis. J Neurogastroenterol Motility. 2019;25(1):82–90.
Mano F, Ikeda K, Joo E, Yamane S, Harada N, Inagaki N. Effects of three major amino acids found in Japanese broth on glucose metabolism and gastric emptying. Nutrition. 2018;46:153–8 e1.
Hill LL, Woodruff LH, Foote JC, Barreto-Alcoba M. Esophageal injury by apple cider vinegar tablets and subsequent evaluation of products. J Am Diet Assoc. 2005;105(7):1141–4.
Johnston CS, White AM, Kent SM. A preliminary evaluation of the safety and tolerance of medicinally ingested vinegar in individuals with type 2 diabetes. J Med Food. 2008;11(1):179–83.
Hlebowicz J, Darwiche G, Bjorgell O, Almer LO. Effect of apple cider vinegar on delayed gastric emptying in patients with type 1 diabetes mellitus: a pilot study. BMC Gastroenterol. 2007;20(7):46.
Petsiou EI, Mitrou PI, Raptis SA, Dimitriadis GD. Effect and mechanisms of action of vinegar on glucose metabolism, lipid profile, and body weight. Nutr Rev. 2014;72(10):651–61.
Yagnik D, Serafin V, Shah AJ. Antimicrobial activity of apple cider vinegar against Escherichia coli, Staphylococcus aureus and Candida albicans; downregulating cytokine and microbial protein expression. Sci Rep. 2018;8(1):1732.
Brown R, Sam CH, Green T, Wood S. Effect of GutsyGum(tm), a novel gum, on subjective ratings of gastro esophageal reflux following a refluxogenic meal. J Diet Suppl. 2015;12(2):138–45.
Yeh Z. Is apple cider vinegar effective for reducing heartburn symptoms related to gastroesophageal reflux disease?: Arizona State University; 2016.
Langella C, Naviglio D, Marino M, Calogero A, Gallo M. New food approaches to reduce and/or eliminate increased gastric acidity related to gastroesophageal pathologies. Nutrition. 2018;54:26–32.
Kines K, Krupczak T. Nutritional interventions for gastroesophageal reflux, irritable bowel syndrome, and hypochlorhydria: a case report. Integr Med. 2016;15(4):49–53.
Majka J, Wierdak M, Brzozowska I, Magierowski M, Szlachcic A, Wojcik D, et al. Melatonin in prevention of the sequence from reflux esophagitis to Barrett’s esophagus and esophageal adenocarcinoma: experimental and clinical perspectives. Int J Mol Sci. 2018;19(7):E2033.
Kandil TS, Mousa AA, El-Gendy AA, Abbas AM. The potential therapeutic effect of melatonin in gastro-esophageal reflux disease. BMC Gastroenterol. 2010;10:7.
Pereira RD. Regression of gastroesophageal reflux disease symptoms using dietary supplementation with melatonin, vitamins and aminoacids: comparison with omeprazole. J Pineal Res. 2006;41(3):195–200.
• Hoshino N, Nishizaki D, Hida K, Obama K, Sakai Y. Rikkunshito for upper gastrointestinal symptoms: a systematic review and meta-analysis. Compl Ther Med. 2019;42:255–63. The results of a recent meta-analysis of 24 studies involving rikkunshito yielded mixed results, with significant relief of upper gastrointestinal symptoms demonstrated by a 5-point symptom score but not by the Gastrointestinal Symptom Rating Scale. Interpretation is limited generally by significant study heterogeneity and specifically by a lack of focus on esophageal symptoms primarily.
Tominaga K, Iwakiri R, Fujimoto K, Fujiwara Y, Tanaka M, Shimoyama Y, et al. Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan. J Gastroenterol. 2012;47(3):284–92.
Tominaga K, Kato M, Takeda H, Shimoyama Y, Umegaki E, Iwakiri R, et al. A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol. 2014;49(10):1392–405.
Kawahara H, Kubota A, Hasegawa T, Okuyama H, Ueno T, Ida S, et al. Effects of rikkunshito on the clinical symptoms and esophageal acid exposure in children with symptomatic gastroesophageal reflux. Pediatr Surg Int. 2007;23(10):1001–5.
Yanai M, Mochiki E, Ogawa A, Morita H, Toyomasu Y, Ogata K, et al. Intragastric administration of rikkunshito stimulates upper gastrointestinal motility and gastric emptying in conscious dogs. J Gastroenterol. 2013;48(5):611–9.
Melzer J, Rosch W, Reichling J, Brignoli R, Saller R. Meta-analysis: phytotherapy of functional dyspepsia with the herbal drug preparation STW 5 (Iberogast). Aliment Pharmacol Ther. 2004;20(11–12):1279–87.
Abdel-Aziz H, Zaki HF, Neuhuber W, Kelber O, Weiser D, Khayyal MT. Effect of an herbal preparation, STW 5, in an acute model of reflux oesophagitis in rats. J Pharmacol Sci. 2010;113(2):134–42.
Allescher HD, Abdel-Aziz H. Mechanism of action of STW 5 in functional dyspepsia and IBS: the origin of multi-target. Dig Dis. 2017;35(Suppl 1):18–24.
Ottillinger B, Storr M, Malfertheiner P, Allescher HD. STW 5 (Iberogast(R))—a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr. 2013;163(3–4):65–72.
Teschke R, Frenzel C, Glass X, Schulze J, Eickhoff A. Greater Celandine hepatotoxicity: a clinical review. Ann Hepatol. 2012;11(6):838–48.
Watts CR, Rousseau B. Slippery elm, its biochemistry, and use as a complementary and alternative treatment for laryngeal irritation. J Investig Biochem. 2010;1(1):17–23.
Yang Y, Wang S, Bao YR, Li TJ, Yang GL, Chang X, et al. Anti-ulcer effect and potential mechanism of licoflavone by regulating inflammation mediators and amino acid metabolism. J Ethnopharmacol. 2017;199:175–82.
Albermann ME, Musshoff F, Hagemeier L, Madea B. Determination of glycyrrhetic acid after consumption of liquorice and application to a fatality. Forensic Sci Int. 2010;197(1–3):35–9.
Tewari SN, Trembalowicz FC. Some experience with deglycyrrhizinated liquorice in the treatment of gastric and duodenal ulcers with special reference to its spasmolytic effect. Gut. 1968;9(1):48–51.
Engqvist A, Von Feilitzen F, Pyk E, Reichard H. Double-blind trial of deglycyrrhizinated liquorice in gastric ulcer. Gut. 1973;14(9):711–5.
Setright R. Prevention of symptoms of gastric irritation (GERD) using two herbal formulas: an observational study. J Austral Trad-Med Soc. 2017;23(2):68.
Sewing KF. Efficacy of low-dose antacids in the treatment of peptic ulcers: pharmacological explanation? J Clin Gastroenterol. 1991;13(Suppl 1):S134–8.
Young GP, Nagy GS, Myren J, Kronborg IJ, Logan KR, Reed PI, et al. Treatment of reflux oesophagitis with a carbenoxolone/antacid/alginate preparation. A double-blind controlled trial. Scand J Gastroenterol. 1986;21(9):1098–104.
DiSilvestro RA, Verbruggen MA, Offutt EJ. Anti-heartburn effects of a fenugreek fiber product. Phytother Res : PTR. 2011;25(1):88–91.
Ku SK, Seo BI, Park JH, Park GY, Seo YB, Kim JS, et al. Effect of Lonicerae Flos extracts on reflux esophagitis with antioxidant activity. World J Gastroenterol. 2009;15(38):4799–805.
Yarnell E, Abascal K. Herbs for gastroesophageal reflux disease. Alternative and Complementary Therapies. 2010;16(6):344–6.
Mittal RK, Holloway R, Dent J. Effect of atropine on the frequency of reflux and transient lower esophageal sphincter relaxation in normal subjects. Gastroenterology. 1995;109(5):1547–54.
Math MV, Khadkikar RM, Kattimani YR. Honey—a nutrient with medicinal property in reflux. Indian J Med Res. 2013;138(6):1020–1.
Vemulapalli R. Diet and lifestyle modifications in the management of gastroesophageal reflux disease. Nutr Clin Pract : official publication of the American Society for Parenteral and Enteral Nutrition. 2008;23(3):293–8.
Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting—a population-based study. Aliment Pharmacol Ther. 2003;17(9):1115–24.
Fass R, Achem SR. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motility. 2011;17(2):110–23.
Schey R, Villarreal A, Fass R. Noncardiac chest pain: current treatment. Gastroenterol Hepatol. 2007;3(4):255–62.
Pimentel M, Bonorris GG, Chow EJ, Lin HC. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol. 2001;33(1):27–31.
• Khalaf MHG, Chowdhary S, Elmunzer BJ, Elias PS, Castell D. Impact of peppermint therapy on dysphagia and non-cardiac chest pain: a pilot study. Dig Dis Sci. 2019. A retrospective analysis of 36 patients treated with peppermint oil for dysphagia and/or non-cardiac chest pain found that 24 (63%) had symptom improvement. The presence of a well-defined esophageal motility disorder was associated with a relatively higher rate of symptom improvement.
Banovcin P, Duricek M, Zatko T, Liptak P, Hyrdel R, Kollarik M. The infusion of menthol into the esophagus evokes cold sensations in healthy subjects but induces heartburn in patients with gastroesophageal reflux disease (GERD). Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2019.
Macpherson H, Dumville JC. Acupuncture as a potential treatment for non-cardiac chest pain—a survey. Acupunct Med: journal of the British Medical Acupuncture Society. 2007;25(1–2):18–21.
Dickman R, Schiff E, Holland A, Wright C, Sarela SR, Han B, et al. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther. 2007;26(10):1333–44.
Zhu J, Guo Y, Liu S, Su X, Li Y, Yang Y, et al. Acupuncture for the treatment of gastro-oesophageal reflux disease: a systematic review and meta-analysis. Acupunct Med : journal of the British Medical Acupuncture Society. 2017;35(5):316–23.
Arora AS, Katzka DA. How do I handle the patient with noncardiac chest pain? Clin Gastroenterol Hepatol : the official clinical practice journal of the American Gastroenterological Association. 2011;9(4):295–304 quiz e35.
Borjesson M, Pilhall M, Eliasson T, Norssell H, Mannheimer C, Rolny P. Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings. Dig Dis Sci. 1998;43(8):1621–8.